Loading the company…
Loading the company…
In the last ten years FDA made 5 decisions for Molli Surgical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2024 (2). The latest was on 2024-09-26.
| Family | Decisions on record |
|---|---|
| Breast biopsy & localization | 5 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2024-09-26 | 510(k) | K234149 | MOLLI 2 System |
| 2024-09-25 | 510(k) | K240042 | MOLLI 2 System |
| 2023-10-26 | 510(k) | K231579 | MOLLI 2 |
| 2023-01-18 | 510(k) | K223107 | MOLLI 2 |
| 2021-04-16 | 510(k) | K210600 | MOLLI |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Molli Surgical.